Philipp Bruns

Philipp Bruns

Auto-generated profile, based on publicly available information

Philipp Bruns

TUM, Department of Surgery, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SMSören Müller
Sören Müller
SRSusanne Raulefs
Susanne Raulefs
PBPhilipp Bruns
Philipp Bruns
FAFabian Afonso-Grunz
Fabian Afonso-Grunz
APAnne Plötner
Anne Plötner
CMChristoph Michalski
Christoph Michalski
Previous studies identified microRNAs (miRNAs) and messenger RNAs with significantly different expression between normal pancreas and pancreatic cancer (PDAC) tissues. Due to technological limitations of microarrays and real-time PCR systems these studies focused on a fixed set of targets. Expression of other RNA classes such as long intergenic non-coding RNAs or sno-derived RNAs has rarely been examined in pancreatic cancer. Here, we analysed the coding and non-coding transcriptome of six PDAC and five control tissues using next-generation sequencing. Besides the confirmation of several deregulated mRNAs and miRNAs, miRNAs without previous implication in PDAC were detected: miR-802, miR-2114 or miR-561. SnoRNA-derived RNAs (e.g. sno-HBII-296B) and piR-017061, a piwi-interacting RNA, were found to be differentially expressed between PDAC and control tissues. In silico target analysis of miR-802 revealed potential binding sites in the 3′ UTR of TCF4, encoding a transcription factor that controls Wnt signalling genes. Overexpression of miR-802 in MiaPaCa pancreatic cancer cells reduced TCF4 protein levels. Using Massive Analysis of cDNA Ends (MACE) we identified differential expression of 43 lincRNAs, long intergenic non-coding RNAs, e.g. LINC00261 and LINC00152 as well as several natural antisense transcripts like HNF1A-AS1 and AFAP1-AS1. Differential expression was confirmed by qPCR on the mRNA/miRNA/lincRNA level and by immunohistochemistry on the protein level. Here, we report a novel lncRNA, sncRNA and mRNA signature of PDAC. In silico prediction of ncRNA targets allowed for assigning potential functions to differentially regulated RNAs.


1 June 2016 in Pancreatology
Verified
Journal Article
Closed access
PDF file
BKBo Kong
Bo Kong
PBPhilipp Bruns
Philipp Bruns
NBNora Behler
Nora Behler
MSMelissa Schlitter
Melissa Schlitter
IRIvonne Regel
Ivonne Regel
CMChristoph Michalski
Christoph Michalski